Master Class: Advanced Kidney Cancer - Evidence-Based Surgical and Systemic Decision-Making

Co-Chair(s)

• 

  Jose Nolazco

  Urologic Oncology Fellow
  Mass General Brigham | Harvard Medical School, United States
• 

  Steven Chang

  Co-Director of the Kidney Cancer Center
  Dana-Farber/Brigham and Women’s Cancer Center, Harvard Medical School, Boston, MA, USA, United States

Presentations:

• 16:00 - 16:10 CET

  Perioperative Crossroads in Localized RCC: Adjuvant Immunotherapy - When and for Whom?
  
• 16:10 - 16:20 CET

  Unexpected Tumor Rupture During Robotic Partial Nephrectomy
  

  Speaker: Riccardo Giuseppe Bertolo – University of Verona
• 16:20 - 16:30 CET

  Local and Regional Recurrence After Nephrectomy
  

  Speaker: Ofer Yossepowitch – Tel Aviv Sourasky University Medical Center (Ichilov), Tel Aviv, Israel
• 16:30 - 16:40 CET

  IVC Tumor Thrombectomy in the Immunotherapy Era: A Modern Playbook For Indications, Techniques, And Robotic Approaches
  

  Speaker: Shawn Dason
• 16:40 - 16:50 CET

  The Contemporary Role of Cytoreductive Nephrectomy in Metastatic RCC
  

  Speaker: Steven L. Chang – Dana-Farber/Brigham and Women’s Cancer Center, Harvard Medical School, Boston, MA, USA
• 16:50 - 17:00 CET

  Systemic Therapy for Advanced RCC: First-Line Selection and Sequencing - What Urologists Need to Know
  
• 17:00 - 17:10 CET

  Delayed Partial Nephrectomy After Immunotherapy for Advanced Kidney Cancer: Feasibility, Patient Selection, and Early Oncologic Outcomes
  
• 17:10 - 17:30 CET

  Discussion/Q&A